{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T08:19:11Z","timestamp":1759133951122},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2010,4,26]],"date-time":"2010-04-26T00:00:00Z","timestamp":1272240000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1007\/s00066-010-2136-z","type":"journal-article","created":{"date-parts":[[2010,4,30]],"date-time":"2010-04-30T01:14:11Z","timestamp":1272590051000},"page":"262-268","source":"Crossref","is-referenced-by-count":33,"title":["High-Grade Acute Organ Toxicity as Positive Prognostic Factor in Primary Radio(chemo)therapy for Locally Advanced, Inoperable Head and Neck Cancer","H\u00f6hergradige Akuttoxizit\u00e4t als positiver prognostischer Faktor bei der prim\u00e4ren Radio(chemo)therapie lokal fortgeschrittener, inoperabler Kopf-Hals-Tumoren"],"prefix":"10.1007","volume":"186","author":[{"given":"Hendrik Andreas","family":"Wolff","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Bosch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaus","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tobias","family":"Overbeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steffen","family":"Hennies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Matthias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clemens F.","family":"Hess","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralph M.","family":"Roedel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans","family":"Christiansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,4,26]]},"reference":[{"key":"2136_CR1","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1200\/JCO.2003.01.008","volume":"21","author":"D.J. Adelstein","year":"2003","unstructured":"Adelstein DJ, Li Y, Adams GL, et al. An Intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol 2003;21:92\u201398.","journal-title":"J Clin Oncol"},{"key":"2136_CR2","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s00066-009-2092-7","volume":"185","author":"P. Balermpas","year":"2009","unstructured":"Balermpas P, Hambek M, Seitz O, et al. Combined cetuximab and reirradiation for locoregional recurrent and inoperable squamous cell carcinoma of the head and neck. Strahlenther Onkol 2009;185:775\u2013781.","journal-title":"Strahlenther Onkol"},{"key":"2136_CR3","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1470-2045(09)70311-0","volume":"11","author":"J.A. Bonner","year":"2010","unstructured":"Bonner JA, Harari PM, Giralt J, et al. Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival. Lancet Oncol 2010;11:21\u201328.","journal-title":"Lancet Oncol"},{"key":"2136_CR4","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ijrobp.2008.01.007","volume":"71","author":"K. Borgmann","year":"2008","unstructured":"Borgmann K, Hoeller U, Nowack S, et al. Individual radiosensitivity measured with lymphocytes may predict the risk of acute reaction after radiotherapy. Int J Radiat Oncol Biol Phys 2008;71:256\u2013264.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2136_CR5","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/hed.1081","volume":"23","author":"G.P. Browman","year":"2001","unstructured":"Browman GP, Hodson DI, Mackenzie RJ, et al. Choosing a concomitant chemotherapy and radiotherapy regimen for squamous cell head and neck cancer: a systematic review of the published literature with subgroup analysis. Head Neck 2001;23:579\u2013589.","journal-title":"Head Neck"},{"key":"2136_CR6","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/0360-3016(95)00060-C","volume":"31","author":"J.D. Cox","year":"1995","unstructured":"Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995;31:1341\u20131346.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2136_CR7","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/S1470-2045(08)70259-6","volume":"9","author":"J. Cuzick","year":"2008","unstructured":"Cuzick J, Sestak I, Cella D, Fallowfield L. Treatment-emergent endocrine symptoms and the risk of breast cancer recurrence: a retrospective analysis of the ATAC trial. Lancet Oncol 2008;9:1143\u20131148.","journal-title":"Lancet Oncol"},{"key":"2136_CR8","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3109\/02841869409098437","volume":"33","author":"O. Dahl","year":"1994","unstructured":"Dahl O, Horn A, Mella O. Do acute side-effects during radiotherapy predict tumour response in rectal carcinoma? Acta Oncol 1994;33:409\u2013413.","journal-title":"Acta Oncol"},{"key":"2136_CR9","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1007\/s00405-007-0395-9","volume":"264","author":"G. Castro de Jr","year":"2007","unstructured":"de Castro G Jr, Snitcovsky IM, Gebrim EM, et al. High-dose cisplatin concurrent to conventionally delivered radiotherapy is associated with unacceptable toxicity in unresectable, non-metastatic stage IV head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol 2007;264:1475\u20131482.","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"2136_CR10","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1002\/hed.20392","volume":"28","author":"E.J. Franzmann","year":"2006","unstructured":"Franzmann EJ, Lundy DS, Abitbol AA, Goodwin WJ. Complete hypopharyngeal obstruction by mucosal adhesions: a complication of intensive chemoradiation for advanced head and neck cancer. Head Neck 2006;28:663\u2013670.","journal-title":"Head Neck"},{"key":"2136_CR11","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1200\/JCO.2004.10.076","volume":"22","author":"B. Jeremic","year":"2004","unstructured":"Jeremic B, Milicic B, Dagovic A, et al. Radiation therapy with or without concurrent low-dose daily chemotherapy in locally advanced, nonmetastatic squamous cell carcinoma of the head and neck. J Clin Oncol 2004;22:3540\u20133548.","journal-title":"J Clin Oncol"},{"key":"2136_CR12","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/BF03038718","volume":"174","author":"T. Kuhnt","year":"1998","unstructured":"Kuhnt T, Richter C, Enke H, Dunst J. Acute radiation reaction and local control in breast cancer patients treated with postmastectomy radiotherapy. Strahlenther Onkol 1998;174:257\u2013261.","journal-title":"Strahlenther Onkol"},{"key":"2136_CR13","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1097\/MLG.0b013e31815ae3d2","volume":"118","author":"U.A. Patel","year":"2008","unstructured":"Patel UA, Thakkar KH, Holloway N. Patient compliance to radiation for advanced head and neck cancer at a tertiary care county hospital. Laryngoscope 2008;118:428\u2013432.","journal-title":"Laryngoscope"},{"key":"2136_CR14","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S0140-6736(00)90011-4","volume":"355","author":"J.P. Pignon","year":"2000","unstructured":"Pignon JP, Bourhis J, Domenge C, Designe L. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer. Lancet 2000;355:949\u2013955.","journal-title":"Lancet"},{"key":"2136_CR15","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/hed.20683","volume":"30","author":"D. Rades","year":"2008","unstructured":"Rades D, Fehlauer F, Sheikh-Sarraf M, et al. Toxicity of two cisplatin-based radiochemotherapy regimens for the treatment of patients with stage III\/IV head and neck cancer. Head Neck 2008;30:235\u2013241.","journal-title":"Head Neck"},{"key":"2136_CR16","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1007\/s00066-009-1989-5","volume":"185","author":"D. Steinmann","year":"2009","unstructured":"Steinmann D, Cerny B, Karstens JH, Bremer M. Chemoradiotherapy with weekly cisplatin 40 mg\/m2 in 103 head-and-neck cancer patients: a cumulative dose-effect analysis. Strahlenther Onkol 2009;185:682\u2013688.","journal-title":"Strahlenther Onkol"},{"key":"2136_CR17","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s00066-007-1683-4","volume":"183","author":"H. Strasser","year":"2007","unstructured":"Strasser H, Grabenbauer GG, Sprung CN, et al. DNA double-strand break induction and repair in irradiated lymphoblastoid, fibroblast cell lines and white blood cells from ATM, NBS and radiosensitive patients. Strahlenther Onkol 2007;183:447\u2013453.","journal-title":"Strahlenther Onkol"},{"key":"2136_CR18","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/s00066-008-1898-z","volume":"184","author":"Y. Tang","year":"2008","unstructured":"Tang Y, Zhang Y, Guo L, et al. Relationship between individual radiosensitivity and radiation encephalopathy of nasopharyngeal carcinoma after radiotherapy. Strahlenther Onkol 2008;184:510\u2013514.","journal-title":"Strahlenther Onkol"},{"key":"2136_CR19","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s00066-009-1992-x","volume":"185","author":"S. Tribius","year":"2009","unstructured":"Tribius S, Kronemann S, Kilic Y, et al. Radiochemotherapy including cisplatin alone versus cisplatin + 5-fluorouracil for locally advanced unresectable stage IV squamous cell carcinoma of the head and neck. Strahlenther Onkol 2009;185:675\u2013681.","journal-title":"Strahlenther Onkol"},{"key":"2136_CR20","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0360-3016(99)00559-3","volume":"47","author":"A. Trotti","year":"2000","unstructured":"Trotti A, Byhardt R, Stetz J, et al. Common Toxicity Criteria: version 2.0. An improved reference for grading the acute effects of cancer treatment: impact on radiotherapy. Int J Radiat Oncol Biol Phys 2000;47:13\u201347.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2136_CR21","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S1053-4296(03)00031-6","volume":"13","author":"A. Trotti","year":"2003","unstructured":"Trotti A, Colevas AD, Setser A, et al. CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 2003;13:176\u2013181.","journal-title":"Semin Radiat Oncol"},{"key":"2136_CR22","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s00066-009-2037-1","volume":"186","author":"H.A. Wolff","year":"2010","unstructured":"Wolff HA, Gaedcke J, Jung K, et al. High-grade acute organ toxicity during preoperative radiochemotherapy as positive predictor for complete histopathologic tumor regression in multimodal treatment of locally advanced rectal cancer. Strahlenther Onkol 2010;186:30\u201335.","journal-title":"Strahlenther Onkol"},{"key":"2136_CR23","unstructured":"Wolff HA, Raus I, Jung K, et al. High-grade acute organ toxicity as positive prognostic factor in primary radiochemotherapy for anal carcinoma. Int J Radiat Oncol Biol Phys 2010:in press."}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-010-2136-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00066-010-2136-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-010-2136-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T22:30:58Z","timestamp":1558564258000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00066-010-2136-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4,26]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["2136"],"URL":"https:\/\/doi.org\/10.1007\/s00066-010-2136-z","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"type":"print","value":"0179-7158"},{"type":"electronic","value":"1439-099X"}],"subject":[],"published":{"date-parts":[[2010,4,26]]}}}